NCT05160090 - Single Dose Crossover Comparative Bioavailability Study of Bupropion Hcl MR Tablet 300mg | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

January 18, 2020

Primary Completion Date

February 5, 2020

Study Completion Date

February 5, 2020

Conditions

Bioequivalence

Interventions

DRUG

Bupropion HCl MR tablets 300mg

In each study period, a single 300 mg dose of Bupropion will be administered orally with about 240 mL of water at ambient temperature, in the morning, while subjects are seated, following a 10-hour overnight fast.

Trial Locations (2)

H3P 3H5

Algorithme Pharma Inc., Mount Royal

H3P 3P1

Algorithme Pharma, Mount Royal